Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues:
Total revenues	$ 11,992	$ 17,436
Expenses:
Cost of goods sold	2,284	4,315
Research and development	3,536	2,442
Selling, general and administrative	20,697	17,413
Gain on foreign currency translation	(1,983)	(3,838)
Total expenses	33,248	23,627
Loss from operations	(21,256)	(6,191)
Other (expense) income:
Interest income, net	377	3
Interest expense on financing liability	(2,371)
Interest expense on notes	(2,748)	(6,452)
Other expense		(276)
Total other expense	(4,742)	(6,725)
Loss before provision for income taxes	(25,998)	(12,916)
Net loss	$ (25,998)	$ (12,916)
Net loss per share - basic and diluted	$ (0.10)	$ (0.05)
Shares used to compute net loss per share - basic and diluted	251,887	246,631
Commercial product sales
Revenues:
Total revenues	$ 9,826	$ 8,099
Collaborations and services
Revenues:
Total revenues	2,166	9,337
Expenses:
Cost of revenue	$ 8,714	$ 3,295